Nuveen Asset Management, LLC Natera, Inc. Transaction History

Nuveen Asset Management, LLC

$340 Billion
Q4 2024

A detailed history of Nuveen Asset Management, LLC transactions in Natera, Inc. stock. As of the latest transaction made, Nuveen Asset Management, LLC holds 583,119 shares of NTRA stock, worth $98.1 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares

583,119

Previous 578,264 0.84%

Holding current value

$98.1 Million

Previous $73.5 Million 25.59%

% of portfolio

0.03%

Previous 0.02%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	BUY	$117.67 - $174.0 $571,287 - $844,770	4,855 Added 0.84%	583,119 $92.3 Million
Q3 2024 Nov 14, 2024	BUY	$97.75 - $129.67 $4.14 Million - $5.49 Million	42,350 Added 7.9%	578,264 $73.5 Million
Q2 2024 Aug 09, 2024	SELL	$85.28 - $112.6 $56.4 Million - $74.4 Million	-660,933 Reduced 55.22%	535,914 $58 Million
Q1 2024 May 13, 2024	SELL	$59.21 - $92.9 $11.3 Million - $17.8 Million	-191,176 Reduced 13.77%	1,196,847 $109 Million
Q4 2023 Feb 14, 2024	BUY	$37.55 - $62.64 $13.9 Million - $23.2 Million	371,113 Added 36.49%	1,388,023 $86.9 Million
Q3 2023 Nov 14, 2023	BUY	$43.4 - $62.52 $32.1 Million - $46.2 Million	739,437 Added 266.49%	1,016,910 $45 Million
Q2 2023 Aug 14, 2023	BUY	$47.08 - $55.16 $390,858 - $457,938	8,302 Added 3.08%	277,473 $13.5 Million
Q1 2023 May 15, 2023	SELL	$36.57 - $58.29 $236,278 - $376,611	-6,461 Reduced 2.34%	269,171 $14.9 Million
Q4 2022 Feb 14, 2023	BUY	$34.17 - $47.91 $1.47 Million - $2.06 Million	43,056 Added 18.51%	275,632 $11.1 Million
Q3 2022 Nov 14, 2022	SELL	$36.93 - $56.68 $58,275 - $89,441	-1,578 Reduced 0.67%	232,576 $10.2 Million
Q2 2022 Aug 15, 2022	BUY	$28.13 - $44.54 $5,682 - $8,997	202 Added 0.09%	234,154 $8.3 Million
Q1 2022 May 16, 2022	SELL	$30.32 - $91.33 $4.22 Million - $12.7 Million	-139,254 Reduced 37.31%	233,952 $9.18 Million
Q4 2021 Feb 14, 2022	SELL	$86.26 - $119.0 $8.56 Million - $11.8 Million	-99,221 Reduced 21.0%	373,206 $34.9 Million
Q3 2021 Nov 12, 2021	SELL	$100.17 - $126.36 $661,422 - $834,355	-6,603 Reduced 1.38%	472,427 $52.6 Million
Q2 2021 Aug 16, 2021	SELL	$86.05 - $119.72 $27.7 Million - $38.5 Million	-321,803 Reduced 40.18%	479,030 $54.4 Million
Q1 2021 May 17, 2021	SELL	$91.47 - $124.36 $1.03 Million - $1.4 Million	-11,283 Reduced 1.39%	800,833 $81.3 Million
Q4 2020 May 17, 2021	BUY	$66.66 - $111.74 $2.17 Million - $3.65 Million	32,626 Added 4.19%	812,116 $80.8 Million
Q4 2020 Feb 16, 2021	SELL	$66.66 - $111.74 $547,545 - $917,832	-8,214 Reduced 1.04%	779,490 $77.6 Million
Q3 2020 Nov 16, 2020	SELL	$45.89 - $72.67 $111,053 - $175,861	-2,420 Reduced 0.31%	787,704 $56.9 Million
Q2 2020 Aug 14, 2020	SELL	$26.36 - $49.86 $511,436 - $967,383	-19,402 Reduced 2.4%	790,124 $39.4 Million
Q1 2020 May 14, 2020	SELL	$17.27 - $40.17 $4.35 Million - $10.1 Million	-251,829 Reduced 23.73%	809,526 $24.2 Million
Q4 2019 Feb 14, 2020	BUY	$32.1 - $40.4 $1.54 Million - $1.93 Million	47,836 Added 4.72%	1,061,355 $35.8 Million
Q3 2019 Nov 14, 2019	BUY	$25.38 - $34.89 $3.36 Million - $4.62 Million	132,376 Added 15.02%	1,013,519 $33.2 Million
Q2 2019 Aug 15, 2019	BUY	$17.75 - $27.58 $15.6 Million - $24.3 Million	881,143 New	881,143 $24.3 Million
Q1 2019 May 14, 2019	SELL	$11.34 - $20.62 $448,224 - $815,026	-39,526 Closed	0 $0
Q4 2018 Feb 14, 2019	SELL	$12.32 - $24.38 $731,401 - $1.45 Million	-59,367 Reduced 60.03%	39,526 $552,000
Q3 2018 Nov 13, 2018	BUY	$18.82 - $28.96 $1.86 Million - $2.86 Million	98,893 New	98,893 $2.37 Million

Others Institutions Holding NTRA

# of Institutions

634

Shares Held

123M

Call Options Held

821K

Put Options Held

1.01M

View Full List

About Natera, Inc.

Ticker NTRA
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 96,957,400
Market Cap $16.3B
Description
Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. It offers Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother, as well as twin pregnancies for zygosity; Vistara, a single-gene mutations screening test to identify sing...

More about NTRA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Nuveen Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nuveen Asset Management, LLC with notifications on news.

Account

Nuveen Asset Management, LLC Natera, Inc. Transaction History